Presepsin Levels of Patients with Crimean-Congo Hemorrhagic Fever
Open Access
- 1 January 2016
- journal article
- Published by Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis in Japanese Journal of Infectious Diseases
- Vol. 69 (6) , 505-509
Abstract
Levels of presepsin (a soluble cluster of differentiation subtype 14 [CD14]) are thought to increase in cases of bacterial infection. CD14 has also been found to play a role in the pathogenesis of various viral diseases. Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic arboviral infection. Our study focuses on presepsin levels as a biomarker for CCHF. Serum presepsin levels in a CCHF group (n = 59) and control group (n = 28) were compared. Patients with CCHF were classified according to severity grading score as having mild, moderate, or severe infection and were allocated to corresponding subgroups (groups 1, 2, and 3, respectively). Presepsin levels were measured in serum samples by using a commercial enzyme-linked immunosorbent assay kit. The mean presepsin levels in the CCHF group as a whole and the healthy group were found to be significantly different (1,499.46 ± 411.96 pg/ml and 430.68 ± 61.21 pg/ml, respectively). The mean presepsin levels of the CCHF subgroups (1, 2 and 3) and the healthy group were also found to be significantly different (1,204.53 ± 371.18, 1,464.21 ± 338.37, 2,007.36 ± 82.18, and 430.68 ± 61.21 pg/ml, respectively) (p < 0.05). We also found that as the severity of the disease increased, the presepsin level also increased. We postulate that the presepsin levels could be used as a supportive biomarker for diagnosis and follow-up of the disease.Keywords
This publication has 28 references indexed in Scilit:
- Crimean-Congo Hemorrhagic Fever Virus Activates Endothelial CellsJournal of Virology, 2011
- An update on crimean congo hemorrhagic feverJournal of Global Infectious Diseases, 2011
- Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosisCytokine & Growth Factor Reviews, 2008
- Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisitedClinical Microbiology and Infection, 2006
- Crimean–Congo hemorrhagic feverAntiviral Research, 2004
- Characteristics of Patients with Crimean-Congo Hemorrhagic Fever in a Recent Outbreak in Turkey and Impact of Oral Ribavirin TherapyClinical Infectious Diseases, 2004
- Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver diseaseJournal of Hepatology, 1995
- Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patientsClinical and Experimental Immunology, 1994
- Immunohistochemical phenotyping of liver macrophages in normal and diseased human liverHepatology, 1994
- The Clinical Pathology of Crimean-Congo Hemorrhagic FeverClinical Infectious Diseases, 1989